Pro-Dex (NASDAQ:PDEX) Announces Quarterly Earnings Results

Pro-Dex (NASDAQ:PDEX) released its quarterly earnings results on Thursday. The medical instruments supplier reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.11, Yahoo Finance reports. Pro-Dex had a return on equity of 6.50% and a net margin of 4.13%. The business had revenue of $15.03 million during the quarter.

Pro-Dex Trading Up 4.6 %

NASDAQ:PDEX opened at $23.28 on Friday. Pro-Dex has a one year low of $14.51 and a one year high of $24.74. The business has a fifty day moving average price of $19.73 and a 200-day moving average price of $18.85. The firm has a market capitalization of $79.62 million, a price-to-earnings ratio of 40.14 and a beta of 0.38. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.45 and a quick ratio of 2.08.

Insider Activity at Pro-Dex

In other Pro-Dex news, Director Angelita Rebamontan Domingo sold 2,585 shares of the company’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $18.30, for a total value of $47,305.50. Following the completion of the sale, the director now owns 8,191 shares in the company, valued at $149,895.30. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 42.60% of the stock is owned by company insiders.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Pro-Dex from a “buy” rating to a “strong-buy” rating in a report on Saturday.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.